Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.

Doreau A, Belot A, Bastid J, Riche B, Trescol-Biemont MC, Ranchin B, Fabien N, Cochat P, Pouteil-Noble C, Trolliet P, Durieu I, Tebib J, Kassai B, Ansieau S, Puisieux A, Eliaou JF, Bonnefoy-Bérard N.

Nat Immunol. 2009 Jul;10(7):778-85. doi: 10.1038/ni.1741. Epub 2009 May 31. Retraction in: Nat Immunol. 2014 Sep;15(9):894.

PMID:
19483719
[PubMed - indexed for MEDLINE]
2.

Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.

Sellam J, Miceli-Richard C, Gottenberg JE, Ittah M, Lavie F, Lacabaratz C, Gestermann N, Proust A, Lambotte O, Mariette X.

Ann Rheum Dis. 2007 Jun;66(6):790-7. Epub 2006 Dec 21.

PMID:
17185325
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

BAFF activates Erk1/2 promoting cell proliferation and survival by Ca2+-CaMKII-dependent inhibition of PP2A in normal and neoplastic B-lymphoid cells.

Liang D, Zeng Q, Xu Z, Zhang H, Gui L, Xu C, Chen S, Zhang S, Huang S, Chen L.

Biochem Pharmacol. 2014 Jan 15;87(2):332-43. doi: 10.1016/j.bcp.2013.11.006. Epub 2013 Nov 22.

PMID:
24269630
[PubMed - indexed for MEDLINE]
4.

Decreased expression of interleukin-21 receptor on peripheral B lymphocytes in systemic lupus erythematosus.

Mitoma H, Horiuchi T, Kimoto Y, Tsukamoto H, Uchino A, Tamimoto Y, Miyagi Y, Harada M.

Int J Mol Med. 2005 Oct;16(4):609-15.

PMID:
16142394
[PubMed - indexed for MEDLINE]
5.

Upregulation of Twist-1 by NF-kappaB blocks cytotoxicity induced by chemotherapeutic drugs.

Pham CG, Bubici C, Zazzeroni F, Knabb JR, Papa S, Kuntzen C, Franzoso G.

Mol Cell Biol. 2007 Jun;27(11):3920-35. Epub 2007 Apr 2.

PMID:
17403902
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.

Nakou M, Papadimitraki ED, Fanouriakis A, Bertsias GK, Choulaki C, Goulidaki N, Sidiropoulos P, Boumpas DT.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2):172-9. Epub 2012 Nov 6.

PMID:
23137515
[PubMed - indexed for MEDLINE]
7.

Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.

Luo J, Niu X, Liu H, Zhang M, Chen M, Deng S.

Mol Immunol. 2013 Dec;56(4):574-82. doi: 10.1016/j.molimm.2013.05.241. Epub 2013 Aug 1.

PMID:
23911415
[PubMed - indexed for MEDLINE]
8.

Interleukin-6 aborts lymphopoiesis and elevates production of myeloid cells in systemic lupus erythematosus-prone B6.Sle1.Yaa animals.

Maeda K, Malykhin A, Teague-Weber BN, Sun XH, Farris AD, Coggeshall KM.

Blood. 2009 May 7;113(19):4534-40. doi: 10.1182/blood-2008-12-192559. Epub 2009 Feb 17.

PMID:
19224760
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases.

Lorenz HM, Grünke M, Hieronymus T, Herrmann M, Kühnel A, Manger B, Kalden JR.

Arthritis Rheum. 1997 Feb;40(2):306-17.

PMID:
9041943
[PubMed - indexed for MEDLINE]
10.

The hierarchical process of differentiation of long-lived antibody-secreting cells is dependent on integrated signals derived from antigen and IL-17A.

Grund LZ, Lopes-Ferreira M, Lima C.

PLoS One. 2013 Sep 18;8(9):e74566. doi: 10.1371/journal.pone.0074566. eCollection 2013.

PMID:
24058589
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

CD40-activated B cells from patients with systemic lupus erythematosus can be modulated by therapeutic immunoglobulins in vitro.

Néron S, Boire G, Dussault N, Racine C, de Brum-Fernandes AJ, Côté S, Jacques A.

Arch Immunol Ther Exp (Warsz). 2009 Nov-Dec;57(6):447-58. doi: 10.1007/s00005-009-0048-3. Epub 2009 Oct 29.

PMID:
19866343
[PubMed - indexed for MEDLINE]
12.

B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupus.

Parameswaran R, Ben David H, Sharabi A, Zinger H, Mozes E.

Clin Immunol. 2009 May;131(2):223-32. doi: 10.1016/j.clim.2008.12.009. Epub 2009 Feb 1.

PMID:
19188092
[PubMed - indexed for MEDLINE]
13.

EDAG regulates the proliferation and differentiation of hematopoietic cells and resists cell apoptosis through the activation of nuclear factor-kappa B.

Li CY, Zhan YQ, Xu CW, Xu WX, Wang SY, Lv J, Zhou Y, Yue PB, Chen B, Yang XM.

Cell Death Differ. 2004 Dec;11(12):1299-308.

PMID:
15332117
[PubMed - indexed for MEDLINE]
Free Article
14.

BAFF-R promotes cell proliferation and survival through interaction with IKKbeta and NF-kappaB/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells.

Fu L, Lin-Lee YC, Pham LV, Tamayo AT, Yoshimura LC, Ford RJ.

Blood. 2009 May 7;113(19):4627-36. doi: 10.1182/blood-2008-10-183467. Epub 2009 Mar 3.

PMID:
19258594
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

[Role of transcription factor ETS-1 and B cell in the pathogenesis of systemic lupus erythematosus].

Ren QJ, Li XP, Tao JH, Yu N, Li XM, Wang GS, Zhang H, Fang X.

Zhonghua Yi Xue Za Zhi. 2013 Aug 20;93(31):2483-6. Chinese.

PMID:
24300270
[PubMed - indexed for MEDLINE]
16.

Long-term B cell depletion in murine lupus eliminates autoantibody-secreting cells and is associated with alterations in the kidney plasma cell niche.

Wang W, Rangel-Moreno J, Owen T, Barnard J, Nevarez S, Ichikawa HT, Anolik JH.

J Immunol. 2014 Apr 1;192(7):3011-20. doi: 10.4049/jimmunol.1302003. Epub 2014 Feb 26.

PMID:
24574498
[PubMed - indexed for MEDLINE]
17.

Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity.

Wong CK, Wong PT, Tam LS, Li EK, Chen DP, Lam CW.

J Clin Immunol. 2010 Jan;30(1):45-52. doi: 10.1007/s10875-009-9325-5. Epub 2009 Sep 23.

PMID:
19774453
[PubMed - indexed for MEDLINE]
18.
19.

B-cell-activating factor inhibits CD20-mediated and B-cell receptor-mediated apoptosis in human B cells.

Saito Y, Miyagawa Y, Onda K, Nakajima H, Sato B, Horiuchi Y, Okita H, Katagiri YU, Saito M, Shimizu T, Fujimoto J, Kiyokawa N.

Immunology. 2008 Dec;125(4):570-90. doi: 10.1111/j.1365-2567.2008.02872.x. Epub 2008 Jun 6.

PMID:
18540961
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Bidirectional effect of interleukin-10 on early murine B-cell development: stimulation of flt3-ligand plus interleukin-7-dependent generation of CD19(-) ProB cells from uncommitted bone marrow progenitor cells and growth inhibition of CD19(+) ProB cells.

Veiby OP, Borge OJ, Mârtensson A, Beck EX, Schade AE, Grzegorzewski K, Lyman SD, Mârtensson IL, Jacobsen SE.

Blood. 1997 Dec 1;90(11):4321-31.

PMID:
9373243
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk